Register for updates


Medicine & Health
RSS Feed
Drug Candidate Stabilizes Essential Transport Mechanism in Nerve Cells
Tuesday, January 31, 2017 9:00:00 AM

NAP blocks formation of "tangles" that contribute to Alzheimer's disease, says TAU researcher

Tau is a key brain protein involved in Alzheimer's disease and other brain diseases. Aggregates of Tau known as "neurofibrillary tangles" have been associated with nerve cell death and cognitive decline.

An important new Tel Aviv University study published in Molecular Psychiatry pinpoints the mechanism harnessed by the drug candidate NAP to block the formation of these harmful neurofibrillary tangles. It facilitates the interaction of Tau with microtubules, the minitubes that serve as "train tracks" for essential movement of biological material in nerve cells.

"Abnormal Tau proteins form tangles that contribute to the progression of Alzheimer's disease," said Prof. Illana Gozes, who led the research for the study. "We showed here, for the first time, that the drug candidate NAP augmented microtubule movement in nerve cells. At the molecular level, NAP, a fragment of activity-dependent neuroprotective protein (ADNP), enhanced Tau-microtubule interactions that block the recruitment of Tau to the tangles observed in Alzheimer's disease and related disorders."

Prof. Gozes is the incumbent of the Lily and Avraham Gildor Chair for the Investigation of Growth Factors, Head of the Elton Laboratory for Molecular Neuroendocrinology at TAU's Sackler Faculty of Medicine and a member of TAU's Adams Super Center for Brain Studies and the Sagol School of Neuroscience.

Stabilizing a neurobiological process

Prof. Gozes is responsible for discovering ADNP, a gene that is dysregulated in Alzheimer's. Mutations in ADNP that occur in pregnancy are a major cause of autism with intellectual disability.

"ADNP and NAP operate through the stabilization of microtubules — tubes within the cell that maintain cellular shape," Prof. Gozes said. "They transport biological material. These microtubules break down in in Alzheimer's disease and may be dysfunctional in autism. NAP works to protect the microtubules, thereby protecting the cell."

"We now discovered that ADNP dramatically enhances Tau binding to the microtubules, protecting them against destruction and against Tau pathology. We further discovered that this action of ADNP is through its NAP fragment, which is now intended for further clinical development."

"Knowing the precise mechanism of its action, it will be much easier to bring NAP to the clinic and to patients," said Prof. Gozes. "Furthermore, the precise mechanism defines a new drug target for autism spectrum disorders, Alzheimer's disease and many other neurodegenerative and neuropsychiatric diseases."

The research for the study was conducted by TAU graduate students Yanina Ivashko-Pachima and Dr. Anna Malishkevich, together with Dr. Laura C. Sayas of Centro de Investigaciones Biomédicas de Canarias. NAP (now called CP201), a Tel Aviv University technology under a term sheet agreement with Coronis Neurosciences, is now planned for future clinical trials in patients with autism, specifically those with ADNP-related syndrome.

Latest News

Koret Foundation Funds $10 Million Collaborative Initiative between TAU, Stanford University, and UC Berkeley

Grant designed to advance breakthroughs in medical and information technology.

Eastern Mediterranean Summer Will be Two Months Longer by End of 21st Century

Climate changes will cut winter in the region by half, TAU researchers say.

Having a Sibling Makes You More Empathetic, Study Finds

Younger and older siblings uniquely contribute to each other's development of empathy, TAU researchers say.

Non-invasive Brain Stimulation Improves Crucial Gait Impairment of Parkinson's Disease Patients

Transcranial direct current therapy positively impacts mobility and executive functions, TAU researchers say.

Search for First Stars Uncovers "Dark Matter"

Discovery offers first direct proof that dark matter exists and that it is made up of low-mass particles, TAU researcher says.

Scientists Discover Critical Molecular Biomarkers of Preeclampsia

Small non-coding RNAs may be used to devise a diagnostic blood test for pregnant women, TAU researchers say.

New Study a Practical Step Towards a "Green" Replacement for Oil

Research on the productivity cycle of macroalgae offers first detailed picture of an economy less dependent on oil, TAU researchers say.

Practical Work-Related Tasks May Reduce Burnout in New Employees

"Emotional" assistance slows workplace integration, TAU researchers say.

Now There's Proof: Sexist Men Have Unsatisfying Relationships

Heterosexual men who hold "patriarchal-reinforcing beliefs" feel anxious and threatened, say TAU researchers.

Liev Schreiber Talks Filmmaking at TAU

The actor, director and screenwriter visiting Israel this week gave a widely-attended masterclass at TAU's Steve Tisch School of Film and Television.


© 2018 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10006 | 212.742.9070 |
Privacy policy | Tel Aviv University